[Mechanical versus biological heart valves].

HOMOGRAFT AORTIC VALVE REPLACEMENT IN AORTIC INCOMPETENCE AND STENOSIS. Thorax (1964) 5.69

Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med (1995) 5.16

Homograft replacement of the aortic valve. Lancet (1962) 5.05

Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation (1994) 3.65

Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31

A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med (1993) 2.50

Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg (1969) 2.04

Risk of strut fracture of Björk-Shiley valves. Lancet (1992) 2.01

Heterologous aortic valve transplantation. Lancet (1965) 1.93

Paraprosthetic leak: a complication of cardiac valve replacement. J Cardiovasc Surg (Torino) (1991) 1.66

Aortic valve replacement with stentless porcine aortic bioprosthesis. J Thorac Cardiovasc Surg (1990) 1.46

Factors influencing hemolysis in valve prosthesis. Am Heart J (1972) 1.45

Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg (1986) 1.44

Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg (1994) 1.40

Prosthetic valve endocarditis. Mayo Clin Proc (1982) 1.36

Risk factors for the development of prosthetic valve endocarditis. Circulation (1985) 1.35

Heterograft aortic valves for human use. Valve bank, techniques of measurement, and implantation. J Thorac Cardiovasc Surg (1967) 1.26

Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest (1995) 1.20

Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg (2001) 1.20

Determinants of the occurrence of and survival from prosthetic valve endocarditis. Experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease. J Thorac Cardiovasc Surg (1994) 1.16

Long term performance of 580 homograft and autograft valves used for aortic valve replacement. Thorac Cardiovasc Surg (1979) 1.13

Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg (1982) 1.12

Preliminary communication heterograft aortic valve transplantation for human valve disease. Med J Aust (1966) 1.10

Frequency and severity of intravascular hemolysis after left-sided cardiac valve replacement with Medtronic Hall and St. Jude Medical prostheses, and influence of prosthetic type, position, size and number. Am J Cardiol (1993) 1.07

Disc immobilization of Björk-Shiley and Medtronic Hall valves during and immediately after valve replacement. Ann Thorac Surg (1987) 1.02

Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg (1995) 1.00

Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg (1994) 0.94

Thrombotic obstruction of the Björk-Shiley valve: the Glasgow experience. Thorax (1984) 0.94

Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol (1985) 0.92

The St. Jude Medical prosthesis. A thirteen-year experience. J Thorac Cardiovasc Surg (1994) 0.91

Thrombosis of mechanical cardiac valves: a qualitative comparison of the silastic ball valve and the tilting disc valve. J Am Coll Cardiol (1984) 0.90

Review of the global experience with the Medtronic-Hall valve. Eur J Cardiothorac Surg (1992) 0.87

Ten-year experience with the porcine bioprosthetic valve: interrelationship of valve survival and patient survival in 1,050 valve replacements. Ann Thorac Surg (1990) 0.85

Aortic valve replacement with stentless porcine bioprostheses. J Card Surg (1988) 0.83

[Short and long term results of aortic valve replacement in patients 80 years of age and older]. Herz (2001) 0.81

Analysis of the Medtronic Intact bioprosthetic valve. Effects of "zero-pressure" fixation. J Thorac Cardiovasc Surg (1991) 0.80

Simultaneous myocardial revascularization and aortic valve replacement: stentless versus stented bioprostheses. Semin Thorac Cardiovasc Surg (1999) 0.80

Late prosthetic valve endocarditis. Immediate and long-term prognosis. Chest (1992) 0.80

Left atrial dimension and risk of systemic embolism in patients with a prosthetic heart valve. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. J Am Coll Cardiol (1990) 0.80

Degeneration in porcine bioprosthetic cardiac valves: incidence of primary tissue failures among 938 bioprostheses at risk. Am J Cardiol (1984) 0.79

[Aortic valve replacement in 80- and over 80-year-old patients. Short-term and long-term results]. Z Gerontol Geriatr (2000) 0.78

Bileaflet, tilting disc and porcine aortic valve substitutes: in vivo hydrodynamic characteristics. J Am Coll Cardiol (1984) 0.78

Thromboembolic risk and late survival after mitral valve replacement with the St. Jude Medical valve. Ann Thorac Surg (1994) 0.78

Aortic valve replacement with the Hancock standard, Björk-Shiley, and Lillehei-Kaster prostheses. A comparison based on follow-up from 1 to 15 years. J Thorac Cardiovasc Surg (1989) 0.78

Aortic valve replacement with or without concomitant coronary artery bypass grafting in the ninth decade of life. Langenbecks Arch Surg (2001) 0.77

Bioprosthetic valve endocarditis: factors affecting bad outcome. J Cardiovasc Surg (Torino) (1992) 0.77

Occlusion of Medtronic Hall mitral valve prosthesis by ruptured papillary muscle and chordae tendineae. J Thorac Cardiovasc Surg (1984) 0.77

Early-onset prosthetic valve endocarditis. Cleve Clin J Med (1994) 0.77

Heterograft valves. An analysis of clinical results of valve replacement. Circulation (1970) 0.76

Ball fracture with the 6120-model Starr-Edwards mitral valve prosthesis occurring late after implantation. J Heart Valve Dis (1993) 0.76

Twenty years' experience with the Model 6120 Starr-Edwards valve in the mitral position. J Thorac Cardiovasc Surg (1987) 0.76

Aortic valve replacement with the Starr-Edwards prosthesis: a comparison of the first and second decades of follow-up. Ann Thorac Surg (1988) 0.76

Hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards track valves) in patients on anticoagulants. Circulation (1978) 0.76

Intravascular haemolysis after valve replacement: comparative study between Starr-Edwards (ball valve) and Björk-Shiley (disc valve) prosthesis. Thorax (1979) 0.75

[Mechanical versus biological heart valves]. Z Kardiol (2001) 0.75